Epidemiologic risk factors associated with breast cancer subtypes. Frequency of L858R and D746-750 EGFR mutations in 411 Caucasian patients with non-small cell lung cancer measured by ...
Combination of eribulin with trastuzumab and pertuzumab for HER2 positive advanced or recurrent breast cancer: JBCRGM03. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This ...
The MarketWatch News Department was not involved in the creation of this content. -- In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Applied Spectral Imaging (ASI, www.spectral-imaging.com) announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results